OKYO Pharma Director Willy Simon's Stock Options and Common Stock Holdings

This SEC Form 3 filing discloses the initial beneficial ownership of OKYO Pharma Ltd (ticker: OKYO) by director Willy Jules Simon. The filing reveals Simon holds 15,383 common shares directly and indirectly, with the indirect holdings (8,948 shares) held by his spouse. More significantly, the filing details extensive stock option grants with various exercise dates and expiration terms extending to 2035. These options include 15,380 shares exercisable at $2.13, 20,000 shares at $1.65, 40,000 shares at $1.46, 12,848 shares at $1.60, and 50,000 shares at $1.50. The options have staggered vesting schedules with exercise dates ranging from 2024 to 2029, indicating long-term compensation alignment with the company's performance. As a director disclosure filing, this provides transparency about insider ownership and compensation structure.